{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:56:49Z","timestamp":1775473009442,"version":"3.50.1"},"reference-count":29,"publisher":"Medical Association of Zenica-Doboj","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicinski Glasnik"],"published-print":{"date-parts":[[2017,8,1]]},"abstract":"<jats:p>&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Aim&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt; To compare finding of thyroid gland scintigraphy with serum concentration of parathyroid hormone in patients undergoing hemodialysis. &amp;lt;br \/&amp;gt;&amp;lt;strong&amp;gt;Methods&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt;This retrospective-prospective study included 50 patients undergoing hemodialysis with established hyperparathyroidism who were treated at Cantonal Hospital Zenica in the period 2009-2014. Besides anthropological data, concentration of parathyroid hormone in serum of patients was monitored too. Scintigraphy was performed at the Department of Nuclear Medicine using two-headed gamma camera Prism 2000xp. &amp;lt;br \/&amp;gt;&amp;lt;strong&amp;gt;Results&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt; Of the total number of 50 patients, 24 (48%) were males and 26 (52%) were females. The average age was 49.34&amp;amp;plusmn;11.82 years. A total of 17 (34%) patients had normal findings of scintigraphy, 11 (22%) had mildly pronounced uptake of radiopharmaceuticals (score of 1), 14 (28%) had moderately pronounced uptake (score of 2), and eight (16%) had intensive uptake of radiopharmaceuticals (score of 3). A statistically significant difference was established in the length of hemodialysis treatment and scintigraphy finding (p=0.041). &amp;lt;br \/&amp;gt;&amp;lt;strong&amp;gt;Conclusion&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt; Scintigraphy of parathyroid glands in patients undergoing hemodialysis allows us to select them for parathyroidectomy. Scintigraphy of parathyroid glands and a value of parathormone in serum should be incorporated into the test algorithm for patients with secondary hyperparathyroidism caused by chronic kidney disease.&amp;lt;\/p&amp;gt;<\/jats:p>","DOI":"10.17392\/864-17","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T10:20:46Z","timestamp":1713694846000},"page":"158-163","source":"Crossref","is-referenced-by-count":0,"title":["Significance of parathyroid scintigraphy and correlation of findings with parathyroid hormone values in patients undergoing hemodialysis"],"prefix":"10.17392","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5740-9171","authenticated-orcid":false,"given":"Nermana","family":"Ahmetbegovi\u0107","sequence":"first","affiliation":[{"name":"Cantonal Hospital Zenica","place":["Zenica,Bosnia and Herzegovina"],"department":["Department of Nuclear Medicine"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadira","family":"Suljagi\u0107","sequence":"additional","affiliation":[{"name":"Public Health Institution Br\u010dko","place":["Br\u010dko,Bosnia and Herzegovina"],"department":["Department of Family Medicine"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahidin","family":"Katica","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Clinical Center Sarajevo","place":["Sarajevo,Bosnia and Herzegovina"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"49509","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"key":"ref1","first-page":"463","article-title":"Mineralno ko\u0161tani poreme\u0107aji u hroni\u010dnoj bubre\u017enoj bolesti","author":"LOstoji\u0107L","year":"2010","unstructured":"Ostoji\u0107 L. Mineralno ko\u0161tani poreme\u0107aji u hroni\u010d-\nnoj bubre\u017enoj bolesti. Medicina Fluminensis 2010; \n46:463-70.","journal-title":"Medicina Fluminensis"},{"key":"ref2","first-page":"18","article-title":"Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease","author":"DAndressD","year":"2008","unstructured":"Andress DL, Coyne DW, Kalantar-Zadeh K, Mo-\nlitch ME, Zangeneh F, Sprague SM. Management \nof secondary hyperparathyroidism in stages 3 and 4 \nchronic kidney disease. Endocr Pract 2008; 14:18-\n27.","journal-title":"Endocr Pract"},{"key":"ref3","first-page":"514","article-title":"Chronic kidney disease-mineral and bone disorder: a complex scenario","author":"NMejiaN","year":"2011","unstructured":"Mejia N, Roman-Garcia P, Miar AB, Tavira B, \nCannata-Andia JB. Chronic kidney disease-mineral \nand bone disorder: a complex scenario. Nefrologia \n2011; 31:514-9.","journal-title":"Nefrologia"},{"key":"ref4","first-page":"121","article-title":"Use of cinacalcet for the management of hyperparathyroidism in patients with different degrees of renal failure","author":"JOrellanaJ","year":"2016","unstructured":"Orellana JM, Esteban RJ, Castilla YA, Fern\u00e1n-\ndez-Castillo R, Nozal-Fern\u00e1ndez G, Esteban \nMA, Garc\u00eda-Valverde M, Bravo J. Use of cinacalcet \nfor the management of hyperparathyroidism in pati-\nents with different degrees of renal failure. Nefrolo-\ngia 2016; 36:121-125.","journal-title":"Nefrologia"},{"key":"ref5","first-page":"10","article-title":"The pleiotropic effects of paricalcitol: Beyond bone-mineral metabolism","author":"JEgidoJ","year":"2016","unstructured":"Egido J, Mart\u00ednez-Castelao A, Bover J, Praga \nM, Torregrosa JV, Fern\u00e1ndez-Gir\u00e1ldez E, Soloz\u00e1bal \nC. The pleiotropic effects of paricalcitol: Beyond bo-\nne-mineral metabolism. Nefrologia 2016; 36:10-8.","journal-title":"Nefrologia"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.medcli.2012.09.025","article-title":"Normocalcemic primary hyperparathyroidism: a growing problem","author":"Mart\u00ednezD\u00edaz-GuerraMart\u00ednez","year":"2013","unstructured":"Mart\u00ednez D\u00edaz-Guerra G, Guadalix Iglesias \nS, Hawkins Carranza F. Normocalcemic primary \nhyperparathyroidism: a growing problem. Med Clin \n(Barc) 2013; 141:125-9.","journal-title":"Med Clin (Barc)"},{"key":"ref7","first-page":"397","article-title":"Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment","author":"MJoyM","year":"2007","unstructured":"Joy MS, Karagiannis PC, Peyerl FW. Outcomes of \nsecondary hyperparathyroidism in chronic kidney \ndisease and the direct costs of treatment. J Manag \nCare Pharm 2007; 13:397-411.","journal-title":"J Manag Care Pharm"},{"key":"ref8","first-page":"1788","article-title":"Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1.3, and 4 study","author":"YSlininY","year":"2005","unstructured":"Slinin Y, Foley RN, Collins AJ. Calcium, phospho-\nrus, parathyroid hormone, and cardiovascular disea-\nse in hemodialysis patients: the USRDS waves 1.3, \nand 4 study. J Am Soc Nephrol 2005; 16:1788-93.","journal-title":"J Am Soc Nephrol"},{"key":"ref9","first-page":"463","article-title":"Mineral and bone disorder in chronic kidney disease","author":"LOrli\u0107L","year":"2010","unstructured":"Orli\u0107 L. Mineral and bone disorder in chronic kidney \ndisease. Medicina Fluminensis 2010; 46:463-70.","journal-title":"Medicina Fluminensis"},{"key":"ref10","first-page":"287","article-title":"Hyperparathyroidism: primary or secondary disease?","author":"ICordellatI","year":"2012","unstructured":"Cordellat IM. Hyperparathyroidism: primary or se-\ncondary disease? Reumatol Clin. 2012; 8:287-91.","journal-title":"Reumatol Clin"},{"key":"ref11","first-page":"1945","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","author":"SMoeS","year":"2006","unstructured":"Moe S, Dr\u00fceke T, Cunningham J, Goodman \nW, Martin K, Olgaard K, Ott S, Sprague S, Lameire \nN, Eknoyan G.Definition, evaluation, and classifi-\ncation of renal osteodystrophy: a position statement \nfrom Kidney Disease: Improving Global Outcomes \n(KDIGO). Kidney Int 2006; 69:1945-53.","journal-title":"Kidney Int"},{"key":"ref12","first-page":"223","article-title":"Decreased bone mineral density in diabetic patients on hemodialysis","author":"HNishitaniH","year":"1991","unstructured":"Nishitani H, Miki T, Morii H, Nishizawa Y, Ishimura \nE, Hagiwara S, Nakatsuka K, Yamakawa M . De-\ncreased bone mineral density in diabetic patients on \nhemodialysis. Contrib. Nephrol 1991; 90:223-7.","journal-title":"Contrib. Nephrol"},{"key":"ref13","first-page":"159","article-title":"Renal osteodystrophy in diabetic patients","author":"YPeiY","year":"1993","unstructured":"Pei Y, Hercz G, Greenwood C, Segre G, Manuel \nA, Saiphoo C, Fenton S, Sherrard D.Renal oste-\nodystrophy in diabetic patients. Kidney Int 1993; \n44:159-64.","journal-title":"Kidney Int"},{"key":"ref14","first-page":"1310","article-title":"The burden of kidney disease: improving global outcomes","author":"GEknoyanG","year":"2004","unstructured":"Eknoyan G, Lameire N, Barsoum R, Eckar-\ndt KU, Levin A, Levin N, Locatelli F, MacLeod \nA, Vanholder R, Walker R, Wang H. The burden of \nkidney disease: improving global outcomes. Kidney \nInt 2004; 66:1310-4.","journal-title":"Kidney Int"},{"key":"ref15","first-page":"266","article-title":"Radionuclide imaging of the parathyroid glands","author":"CPalestroC","year":"2005","unstructured":"Palestro CJ, Tomas MB, Tronco GG. Radionuclide \nimaging of the parathyroid glands. Semin Nucl Med \n2005; 35:266-76.","journal-title":"Semin Nucl Med"},{"key":"ref16","first-page":"296","article-title":"Contribution of intraoperative scintigraphy to the detection of intrathyroidal parathyroid adenoma","author":"RD\u00edaz-Exp\u00f3sitoR","year":"2014","unstructured":"D\u00edaz-Exp\u00f3sito R, Cas\u00e1ns-Tormo I, Cassinello-\nFern\u00e1ndez N, Ortega-Serrano J, Mut-D\u00f3lera T. Con-\ntribution of intraoperative scintigraphy to the detec-\ntion of intrathyroidal parathyroid adenoma. Rev Esp \nMed Nucl Imagen Mol 2014; 33:296-8.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"ref17","first-page":"3","article-title":"Rezultati lije\u010denja dijalizama u Srbiji: 10 godina kasnije. Monografije nau\u010dnih skupova","author":"DukanovidLjDukanovid","year":"2010","unstructured":"Dukanovid Lj, Alcsio-Milidevid B, Antic M. Rezul-\ntati lije\u010denja dijalizama u Srbiji: 10 godina kasnije. \nMonografije nau\u010dnih skupova. AMN SLD 2010; 1:3.","journal-title":"AMN SLD"},{"key":"ref18","first-page":"85","article-title":"Current concepts and management strategies in chronic kidney disease-mineral and bone disorder","author":"VChauhanV","year":"2012","unstructured":"Chauhan V, Kelepouris E, Chauhan N, Vaid M. Cu-\nrrent concepts and management strategies in chronic \nkidney disease-mineral and bone disorder. South \nMed J 2012; 105:479:85.","journal-title":"South Med J"},{"key":"ref19","first-page":"875","article-title":"Metabolic bone disease in chronic kidney disease","author":"KMartinK","year":"2007","unstructured":"Martin KJ, Gonzales EA. Metabolic bone disease \nin chronic kidney disease. J Am Soc Nephrol 2007; \n18:875-85.","journal-title":"J Am Soc Nephrol"},{"key":"ref20","first-page":"244","article-title":"Surgery for primary hyperparathyroidism: experience with 500 consecutive cases and evaluation of the role of surgery in the asymptomatic patient","author":"CRussellC","year":"1982","unstructured":"Russell CF, Edis AJ. Surgery for primary hyperpa-\nrathyroidism: experience with 500 consecutive cases \nand evaluation of the role of surgery in the asympto-\nmatic patient. Br J Surg 1982; 69:244-7.","journal-title":"Br J Surg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archsurg.141.1.33","article-title":"Parathyroid graft function after presternal subcutaneous autotransplantation for renal hyperparathyroidism","author":"MEchenique-ElizondoM","year":"2006","unstructured":"Echenique-Elizondo \nM, \nD\u00edaz-Aguirregoitia \nFJ, Amondarain JA, Vidaur F. Parathyroid graft \nfunction after presternal subcutaneous autotran-\nsplantation for renal hyperparathyroidism. Arch \nSurg 2006; 141:33-8.","journal-title":"Arch Surg"},{"key":"ref22","first-page":"24","article-title":"Parathyroid scintigraphy: optimizing preoperative localization","author":"PClarkP","year":"2005","unstructured":"Clark PB. Parathyroid scintigraphy: optimizing pre-\noperative localization. Appl Radiol 2005; 34:24-8.","journal-title":"Appl Radiol"},{"key":"ref23","first-page":"106","article-title":"Renalna osteodistrofija kod pacijenata na hemodijalizi","author":"HResi\u0107H","year":"2009","unstructured":"Resi\u0107 H, Ku\u010dukali\u0107 Selimovi\u0107 E, Kapid\u017ei\u0107 A, Kuka-\nvicaN, \u0160ahovi\u0107 V, Ma\u0161ni\u0107 F. Renalna osteodistrofija \nkod pacijenata na hemodijalizi. Medicinski \u017eurnal \n2009; 15:106-10.","journal-title":"Medicinski \u017eurnal"},{"key":"ref24","first-page":"17","article-title":"Poreme\u0107aji mineral kostiju kod bolesnika na dijalizi u zdravstvenom centru Novi Pazar","author":"EHad\u017eibuli\u0107E","year":"2010","unstructured":"Had\u017eibuli\u0107 E, Bir\u0111ozli\u0107 \u0160.F. Poreme\u0107aji mineral ko-\nstiju kod bolesnika na dijalizi u zdravstvenom centru \nNovi Pazar. Sanamed 2010; 5:17-20.","journal-title":"Sanamed"},{"key":"ref25","first-page":"34","article-title":"Lije\u010denje sekundarnog hiperparatireoidizma malim dozama sinakalceta i parikalcitolom","author":"MKudamijaM","year":"2014","unstructured":"Kudamija M, Dits S, Hr\u0161ak PI, Mihovilovi\u0107 K, \nPavlovi\u0107 D. Lije\u010denje sekundarnog hiperparatireoi-\ndizma malim dozama sinakalceta i parikalcitolom. \nActa Med Croatica 2014; 68:34-38.","journal-title":"Acta Med Croatica"},{"key":"ref26","first-page":"30","article-title":"Parikalcitrol u lije\u010denju sekundarnog hiperparatireoidizma u starijih osoba","author":"Deteli\u0107ReihelmDeteli\u0107","year":"2014","unstructured":"ReihelM, Deteli\u0107 D, \u0160eferS, Pavlovi\u0107 D. Parikalci-\ntrol u lije\u010denju sekundarnog hiperparatireoidizma u \nstarijih osoba. Acta Med Croatica 2014; 68:30-3.","journal-title":"Acta Med Croatica"},{"key":"ref27","first-page":"1","article-title":"Improving Global Outcomes (KDI-GO) CKD-MBD Work Group. KDIGO Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease -Mineral and Bone Disorder (CKD-MBD)","author":"Kidneydisease","year":"2009","unstructured":"KidneyDisease: Improving Global Outcomes (KDI-\nGO) CKD-MBD Work Group. KDIGO Clinical \npractice guideline for the diagnosis, evaluation, pre-\nvention, and treatment of Chronic Kidney Disease \n-Mineral and Bone Disorder (CKD-MBD). Kidney \nInt Suppl 2009; 113:S1-130.","journal-title":"Kidney Int Suppl"},{"key":"ref28","first-page":"166","article-title":"Preoperative detection of parathyroid adenomas with Tc-99m MIBI and Tc-99m pertechnetate scintigraphy: histopathological and biochemical correlation with Tc-99m MIBI uptake","author":"MAkinM","year":"2009","unstructured":"Akin M, Atasever T, Kurukahvecioglu O, Dogan \nM, Gokaslan D, Poyraz A, Koksal H, Taneri F. Preo-\nperative detection of parathyroid adenomas with Tc-\n99m MIBI and Tc-99m pertechnetate scintigraphy: \nhistopathological and biochemical correlation with \nTc-99m MIBI uptake. Bratisl Lek Listy 2009; \n110:166-9.","journal-title":"Bratisl Lek Listy"},{"key":"ref29","first-page":"209","article-title":"The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease","author":"WGoodmanW","year":"2004","unstructured":"Goodman WG. The consequences of uncontrolled \nsecondary hyperparathyroidism and its treatment in \nchronic kidney disease. Semin Dial 2004; 17:209-16.","journal-title":"Semin Dial"}],"container-title":["Medicinski Glasnik"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medicinskiglasnik.ba\/article\/351\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicinskiglasnik.ba\/article\/351\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:43:43Z","timestamp":1775468623000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicinskiglasnik.ba\/article\/id\/108\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,8,1]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.17392\/864-17","archive":["Internet Archive"],"relation":{},"ISSN":["1840-0132","1840-0132"],"issn-type":[{"value":"1840-0132","type":"electronic"},{"value":"1840-0132","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}